期刊文献+

肥胖与非肥胖老年高血压患者血清生长激素水平比较及相关因素分析 被引量:3

Analysis of growth hormone level and related factors in obese and non-obese elderly patients with hypertension
下载PDF
导出
摘要 目的比较肥胖与非肥胖老年高血压患者血清生长激素(GH)水平的差异,探讨其与心血管危险因素的相关性。方法根据体质量指数(BMI)及腰围(WC),将80例老年高血压患者分为肥胖组及非肥胖组,测定WC、GH、空腹血糖(FPG)、空腹胰岛素(FINS)、血脂、纤维蛋白原(Fb)、收缩压(SBP)、舒张压(DBP),C反应蛋白(CRP),计算胰岛素抵抗指数(HOMA-IR)。结果 (1)肥胖组GH、高密度脂蛋白胆固醇(HDL-C)低于非肥胖组,两者差异均有统计学意义(P<0.05或P<0.01);(2)肥胖组FPG、FINS、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、Fb、SBP、DBP、CRP、HOMA-IR高于非肥胖组,2组差异均有统计学意义(P<0.05或P<0.01);(3)GH与HDL-C呈正相关,与WC、BMI、HOMA-IR、TG、TC、CRP、Fb及年龄呈负相关。结论肥胖的患者GH水平下降,并与心血管危险因素密切相关,GH水平降低可能预示心血管疾病的高风险。 Objective To compare the difference of growth hormone (GH) between obese and non-obese in elderly patients with hypertension, and to investigate the relativity between GH and the risk of cardiovascular disease. Methods According to different body mass index(BMI) and waist circumferences(WC) ,80 subjects were divided into two groups: obesity group and non-obesity group. WC, GH, fasting plasma glucose ( FPG), fasting insulin ( FINS), lipid, fibrin ( Fb), C reactive protein (CRP) ,systolic blood pressure(SBP) ,diastolic blood pressure(DBP) were measured. HOMA-IR was calculated. Results ( 1 ) GH and HDL-C in patients with obesity decreased remarkably as compared with non-obesity group ( P 〈 0. 05 or P 〈 0. 01 ). ( 2 ) FPG, FINS,TG, TC, LDL-C, Fb, CRP, SBP, DBP and HOMA-IR were elevated significently in obese patients( P 〈 0.05 or P 〈 0.01 ). (3) GH was positively correlated with HDL-C, and negatively correlated with WC, BMI, HOMA-IR,TG,TC,LDL-C,Fb,CRP and age. Conclusions The level of GH significantly decreases in obese patients, and it is highly related to cardiovascular risk. Decreased GH secretion may be associated with increased high risk of cardiovascular disease.
出处 《实用老年医学》 CAS 2011年第1期58-61,共4页 Practical Geriatrics
关键词 生长激素 肥胖 高血压 胰岛素抵抗 growth hormone obesity hypertension insulin resistance
  • 相关文献

参考文献18

  • 1Misra M,Bredella MA,Tsai P,et al.Lower growth hormone and higher cortisol are associated with greater visceral adiposity,intramyocellular lipids,and insulin resistance in over weight girls[J].Am J Physiol Endocrinol Metab,2008,295(2):E385-E392.
  • 2Franco C,Brandberg J,Lonn L,et al.Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity:a 12-month placebo-controlled trial[J].J Clin Endocrinol Metab,2005,90(3):1466-1474.
  • 3Ferrannini E,Balkau B,Coppack SW,et al.Insulin resistance,insulin response,and obesity as indicators of metabolic risk[J].J Clin Endocrinol Metab,2007,92(8):2885-2892.
  • 4Despres JP.Is visceral obesity the cause of the metabolic syndrome?[J].Ann Med,2006,38(1):52-63.
  • 5Mathew B,Francis L,Kagalar A,et al.Obesity:Effects on cardiovascular disease and its diagnosis[J].J Am Board Fam Med,2008,21(6):562-568.
  • 6Lurbe E,Torro I,Aguilar F,et al.Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents[J].Hypertension,2008,51(3):635-641.
  • 7Wooten N,Bakalov VK,Hills,et al.Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with turner syndrome[J].J Clin Endocrinol Metab,2008,93(6):2109-2114.
  • 8Yeckel CW,Dziura J,DiPietro L.Abdominal obesity in older women:potential role for disrupted fatty acid reesterification in insulin resistance[J].J Clin Endocrinol Metab,2008,93(4):1285-1291.
  • 9沈备.老年单纯性肥胖者胰岛素抵抗的研究[J].实用老年医学,2002,16(6):312-313. 被引量:1
  • 10Tannenbaum GS,Epelbaum J,Bowers CY.Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion[J].Endocrinology,2003,144(3):967-974.

二级参考文献2

同被引文献33

  • 1中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防控制指南[M],北京:人民卫生出版社,2006,1-20.
  • 2World Health Organization. Global status report on non-com- municable diseases 2010 [ R]. Geneva: WHO Library Cata- loguing-in-Publication Data, 2010: 2-23.
  • 3Bloch MJ, Viera AJ. Should patients with obesity and hyper- tension be treated differently from those who are not obese [ J ].Curr Hypertens Rep, 2014, 16 (3) : 418.
  • 4World Health Organization.The WHO STEP wise approach to chronic disease risk factor surveillance [ R]. Geneva, 2006.
  • 5中国疾病预防控制中心慢性非传染性疾病预防控制中心.中国慢性病其危险因素监测报告(2010)[M].北京:军事医学科学出版社,2012.
  • 6卫生部疾病预防控制局.全国慢性病预防控制工作规范(试行).北京,2011.
  • 7Thadhani R, Camargo CA Jr, Stampfer M J, et al. Prospective study of moderate alcohol consumption and risk of hypertension in young women [ J ]. Arch Intern Med, 2002, 162(5) :569-574.
  • 8Aswathappa J, Garg S, Kutty K, et al. Neck circumference as an anthropometric measure of obesity in diabetics [ J]. N Am J Med Sci, 2013,5(1) : 28-31.
  • 9Kelly T, Yang W, Cben CS, et al. Global burden of obesity in 2005 and projections to 2030 [ J]. Int J Obes, 2008, 32 (9) :1431-1437.
  • 10Karaea U, Schram MT, Houben A J, et al. Mierovascular dysfunction as a link between obesity ,insulin resistance and hy- pertension[J] .Diabetes Res Clin Pratt, 2014, 103(3) :382-387.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部